香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司證券之邀請或要約。 茲提述中國儲能科技發展有限公司（「本公司」）日期為二零二四年十二月十三日、 二 零 二 五 年一 月 二 日 、 二 零 二 五 年一 月 七 日 及 二 零 二 五年 二 月 四 日 內 容 有 關（ 其 中 包 括 ）供 股 、 更 改 每 手 買 賣 單 位 、 配 售 事 項 及 轉 讓 的 公 告（「該 等 公 告」）。 除 文 義另有所指外，本公告所用詞彙與該等公告所界定者具相同涵義。 – 1 – 進一步延遲寄發通函 誠如該等公告所披露，載有（ 其中包括 ）(i)供股、配售事項、更改每手買賣單位及 轉讓以及據此擬進行的交易之進一步詳情；(ii)獨立董事委員會就供股發出之推薦 建 議 函 件 ； (iii ) 獨 立 財 務 顧 問 就 供 股 致 獨 立 董 事 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司證券之邀請或要約。 （前稱環亞國際醫療科技集團有限公司） （於開曼群島註冊成立的有限公司） （股份代號：1143） 有關 I .建議按於記錄日期每持有一(1)股現有股份獲發 兩(2)股供股股份的基準進行供股； II .建議更改每手買賣單位；及 III .有關轉讓分銷權的主要交易 進一步延遲寄發通函及經修訂時間表 本公司之聯席配售代理 茲提述中國儲能科技發展有限公司（「本公司」）日期為二零二四年十二月十三日、 二零二五年一月二日及二零二五年一月七日內容有關（ 其中包括 ）供股、更改每手 買賣單位、配售事項及轉讓的公告（「該等公告」）。除文義另有所指外，本公告所 用詞彙與該等公告所界定者具相同涵義。 – 1 – 進一步延遲寄發通函 誠如該等公告所披露，載有（ 其中包括 ）(i)供股、配售事項、更改 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司證券之邀請或要約。 （前稱環亞國際醫療科技集團有限公司） （於開曼群島註冊成立的有限公司） （股份代號：1143） I .建議按於記錄日期每持有一(1)股現有股份獲發 兩(2)股供股股份的基準進行供股； II .建議更改每手買賣單位；及 III .有關轉讓分銷權的主要交易 延遲寄發通函及經修訂時間表 本公司之聯席配售代理 茲提述中國儲能科技發展有限公司（「本公司」）日期為二零二四年十二月十三日及 二零二五年一月二日內容有關（ 其中包括 ）供股、更改每手買賣單位、配售事項及 轉讓的公告（「該等公告」）。除文義另有所指外，本公告所用詞彙與該等公告所界 定者具相同涵義。 – 1 – 延遲寄發通函 誠如該等公告所披露，載有（ 其中包括 ）(i)供股、配售事項、更改每手買賣單位及 轉讓以及據此擬進行的交 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司證券之邀請或要約。 （前稱環亞國際醫療科技集團有限公司） （於開曼群島註冊成立的有限公司） （股份代號：1143） 成立獨立董事委員會及 委任獨立財務顧問 獨立董事委員會及獨立股東之獨立財務顧問 成立獨立董事委員會 董 事 會 欣 然宣 佈 ， 由 全 體 獨 立 非 執行 董 事（ 即李 慧 武 先 生 、 胡 子 敬 先生 及 張 秀 琳 女 士 ）組 成 之 獨 立 董 事 委員 會 已 告 成 立 ， 以 就供 股 條 款 是 否 屬 公 平 合理 及 符 合 本 公司及股東整體利益向獨立股東提供意見，並就獨立股東如何於股東特別大會上 投票向獨立股東提供意見。 – 1 – 委任獨立財務顧問 董 事 會 亦 欣然 宣 佈 ， 於 二 零 二 五 年一 月 二 日 ， 榮 高 金 融有 限 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司證券之邀請或要約。 （前稱環亞國際醫療科技集團有限公司） （於開曼群島註冊成立的有限公司） （股份代號：1143） I . 建議按於記錄日期每持有一(1)股現有股份獲發 兩(2)股供股股份的基準進行供股； II . 建議更改每手買賣單位；及 III . 有關轉讓分銷權的主要交易 本公司之聯席配售代理 I . 建議供股 本公司建議以供股方式按認購價每股供股股份0.21港元，按於記錄日期營業 時間結束時合資格股東每持有一(1)股現有股份可獲發兩(2)股供股股份的基 準發行最多448,578,370股供股股份（ 假設記錄日期或之前的已發行股份數目 並 無 變 動 ）， 籌 集 最 多 約 94.2 百 萬 港 元 的 所 得 款 項 總 額（ 假 設 供 股 獲 全 數 認 購）。 – 1 – 假設 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 （前稱環亞國際醫療科技集團有限公司） （於開曼群島註冊成立的有限公司） 本公司董事（「董事」）會（「董事會」）欣然宣佈，本公司已經在中國江蘇省鹽城市註 冊成立一間全資擁有的子公司，名為江蘇碧澤科技發展有限公司，法定代表人為 本公司董事卞蘇蘭女士。主營業務為發展新能源項目營運。董事相信江蘇碧澤科 技發展有限公司的設立可促進本公司儲能科技發展業務板塊發展，尋求新的發展 方向與利潤增長點。 於本公告日期，江蘇碧澤科技發展有限公司尚未開始任何業務，也沒有任何收入 記錄。 本集團預期江蘇碧澤科技發展有限公司的設立對集團截至二零二四年十二月三十 一日止年度本集團的財務狀況和經營成果不會構成重大影響。 承董事會命 （股份代號：1143） 自願公告 註冊成立一間全資子公司 本公 告由中 國儲 能科技 發展有 限公司（「本 公司」，連 同其附 屬公司 統稱 ...

10月24日，港股中国储能科技发展（01143.HK）尾盘一度暴跌88%，截至收盘跌75.46%，成交额1.21亿 港元，换手率33.879%，振幅87.732%。 当日大跌导致公司市值大幅缩水至1.19亿港元。 公开资料显示，中国储能科技发展于2010年成立，2011年1月即实现登陆港股。 上市之初，公司主营业务分为电子制造服务和分销业务，电子制造服务包括电器和电器控制产品，分销 业务则主要包括电讯产品、多媒体产品和电脑配件的推广和分销。 此后，中国储能科技发展频频切入医疗、储能等资本市场热点概念。 不过，主营业务方面，公司目前仍是一家主要从事电子制造相关业务的投资控股公司。 中国储能科技发展通过两个业务分部进行运营。 电子制造服务分部从事提供电子制造服务业务。 电讯产品分销分部从事市场推广及分销电讯产品业务。 该供公司也通过其子公司从事物业投资、买卖美容护肤产品及电子医疗设备，以及提供咨询代理服务业 务。 中国储能科技发展上市后业绩频频亏损。 2014年至2023年，公司连续10年主业亏损。 2024年上半年财报显示，公司上半年收入为2.65亿港元，同比增长15.86%，股东应占亏损为390.8万港 元， ...

Revenue Performance - Revenue increased by approximately HK$36.2 million or 15.8% to approximately HK$264.7 million for the period ended 30 June 2024, compared to HK$228.5 million for the same period in 2023[5] - EMS segment revenue rose by approximately HK$49.6 million or 25.1% to approximately HK$247.4 million for the period ended 30 June 2024, up from HK$197.8 million in 2023[5] - Revenue from the distribution of Communication Products decreased by 97.6% to HK$0.2 million for the period ended 30 June 2024, down from HK$8.2 million in 2023[5] - Revenue from Real Estate Supply Chain Services increased by 11.6% to HK$4.8 million for the period ended 30 June 2024, compared to HK$4.3 million in 2023[5] - Securities and Other Assets Investment segment contributed approximately HK$12.2 million in revenue for the six months ended 30 June 2024, down from HK$18.0 million in 2023[5] - The revenue growth in the EMS segment was attributed to the easing of pandemic-related market conditions in 2024[5] - Revenue contributions from major European countries totaled HK$95.4 million, accounting for 36.0% of the Group's total turnover[27] - The US market contributed HK$71.7 million in revenue, representing 27.1% of total turnover[27] - Revenue from the People's Republic of China and other countries amounted to HK$33.3 million and HK$64.3 million, respectively[27] - Revenue for the six months ended June 30, 2024, was HK$247,369,000, a significant increase of 25.0% compared to HK$197,813,000 for the same period in 2023[128] - The Group's revenue from external customers for the six months ended June 30, 2024, was HK$264,698,000, up from HK$228,457,000 in 2023, indicating a growth of 15.9%[128] Financial Position and Performance - The loss attributable to owners of the Company was HK$3.9 million for the period ended 30 June 2024, with a net profit margin of -1.5%, an improvement from -2.1% in 2023[30] - As of 30 June 2024, the Group's current ratio was 2.8 times, up from 2.6 times on 31 December 2023, with cash and cash equivalents totaling HK$293.0 million[34] - Total borrowings increased to approximately HK$7.8 million as of 30 June 2024, compared to HK$4.8 million on 31 December 2023[34] - The gearing ratio was 37.7% as of 30 June 2024, slightly up from 37.1% on 31 December 2023[34] - The Group reported a total comprehensive income for the period of HK$(10,745,000) for the six months ended June 30, 2024[95] - The accumulated losses as of June 30, 2024, were HK$(535,408,000)[95] - The cash and cash equivalents at the end of the period stood at HK$293,045,000, compared to HK$255,479,000 at the end of the previous period[98] - Total assets as of June 30, 2024, amounted to HK$798,098,000, an increase from HK$776,418,000 as of December 31, 2023[88] - Current assets increased to HK$743,399,000 from HK$705,931,000, reflecting a growth in liquidity[88] - Non-current assets decreased to HK$54,699,000 from HK$70,487,000, indicating a reduction in long-term asset holdings[88] - Total liabilities increased to HK$300,642,000 from HK$287,693,000[91] Money Lending Business - As of June 30, 2024, the Group's money lending segment generated revenue of approximately HK$0.1 million, accounting for about 0.04% of overall revenue[7] - The operating loss from the money lending business segment amounted to approximately HK$0.2 million as of June 30, 2024[7] - The Group had 4 active loan accounts as of June 30, 2024, all of which were individual customers[7] - The percentage of loans and interest receivables from the four customers ranged from approximately 20.5% to 33.4% of the total loans and interest receivables under the money lending segment[7] - The Group's loan portfolio as of June 30, 2024, consisted of 4 unsecured loans totaling HK$2.39 million, with an interest rate of 10% per annum[9] - The gross amount of loan and interest receivables as of June 30, 2024, was HK$2.39 million, with an allowance for expected credit losses of HK$748, resulting in a net amount of HK$1.85 million[10] - The Group plans to explore further potential money lending business opportunities while maintaining effective controls for loan approvals and credit monitoring[7] - The source of funds for the money lending business is generally funded by the internal resources of the Group[7] - The management remains alert and will prudently maintain compliance matters applicable to all aspects of the money lending business[7] - The Group's money lending business is newly commenced and focused on unsecured loans, with no specific target customer group identified[7] Impairment and Credit Risk Management - The Group's impairment losses primarily relate to loans and interest receivables, assessed based on historical credit loss experience and adjusted for specific debtor factors[18] - Loans are classified into three stages based on credit risk: Stage 1 (no significant increase), Stage 2 (increase in credit risk), and Stage 3 (significant increase and credit-impaired)[18][19] - The expected credit loss (ECL) model considers the expected life and contractual terms of financial instruments, market probability of default, and forward-looking market data[18][19] - The Group regularly reviews each loan grouping to ensure similar credit risk characteristics among constituents[18] - Management determines loan amounts and interest rates based on the financial strength and repayment ability of borrowers and guarantors[18] - The Group has established strict credit policies and controls to mitigate all associated credit risks[15] - The management is responsible for assessing and approving loans within predetermined credit limits[15] - The Group has intensified efforts in the recovery procedures for loans receivables to minimize potential credit losses[15] - Legal actions will be taken on a case-by-case basis to minimize any possible credit losses, considering normal market practices[15] Share Options and Capital Management - A total of 35,671,850 share options were granted on 28 January 2021, and 53,328,000 share options were granted on 14 June 2022, both under the 2020 Share Option Scheme[67] - On 8 June 2023, the adoption of the 2023 Share Option Scheme and Share Award Plan was approved by shareholders[67] - A total of 15,695,082 share options were granted on 3 November 2023 under the 2023 Share Option Scheme[68] - The weighted average closing price of the shares before the exercise of options during the six months ended 30 June 2024 was HK$2.19 per share[68] - The total number of shares that may be issued in respect of options granted under all schemes during the six months ended 30 June 2024 was approximately 9.2% of the weighted average number of shares in issue for that period[68] - The share options scheme aims to reward and recognize the contributions of grantees to the Group[73] - The share options granted during the six months ending June 30, 2024, were not exercised[69] - The share options scheme does not include a clawback mechanism[72] - The Company did not grant any share options to directors or senior managers during the six months ended June 30, 2024[80] Operational and Strategic Focus - The company continues to assess its business strategies in response to the uncertain global economic environment[5] - The Group aims to enhance its product portfolio, particularly in energy storage and clean energy, to align with China's renewable energy development[58] - The Group plans to focus on strategic objectives in the second half of 2024, enhancing core competitiveness through channel optimization and customer service improvements[58] - The external development environment remains challenging in the post-pandemic era, requiring prompt and effective responses to maintain competitiveness[58] Compliance and Governance - The Audit Committee, consisting of three independent non-executive directors, has reviewed the Group's accounting principles and the unaudited interim financial statements for the six months ended June 30, 2024[63] - The Board does not recommend the payment of an interim dividend for the period (2023: nil) [65] - The company ensures compliance with applicable laws and regulations, particularly the Money Lenders Ordinance and AML & CTF regulations[21] - The company is listed on the Hong Kong Stock Exchange under stock code 1143[194]

Financial Performance - Revenue for the six months ended June 30, 2024, was HKD 264,698,000, representing an increase of 15.9% compared to HKD 228,457,000 for the same period in 2023[2] - Gross profit for the same period was HKD 73,724,000, up 34.8% from HKD 54,680,000 year-on-year[2] - The company reported a net loss of HKD 4,786,000 for the six months ended June 30, 2024, compared to a loss of HKD 3,691,000 in the prior year, indicating a deterioration in performance[3] - Basic loss per share was HKD 1.96, compared to HKD 2.98 for the same period last year[4] - The group reported a total profit of HKD 3,613,000 for the six months ended June 30, 2024, compared to HKD 3,276,000 for the same period in 2023, indicating an increase of about 10.3%[14] - The group reported a net loss attributable to shareholders of HKD 3,900,000, an improvement from a loss of HKD 4,800,000 in 2023[59] Assets and Liabilities - Total assets as of June 30, 2024, amounted to HKD 798,098,000, an increase from HKD 776,418,000 as of December 31, 2023[7] - Non-current assets decreased to HKD 54,699,000 from HKD 70,487,000 year-on-year, primarily due to a reduction in intangible assets[6] - Current liabilities totaled HKD 266,168,000, slightly down from HKD 272,691,000 in the previous year[7] - The total liabilities of the group were reported at HKD 300,642,000 as of June 30, 2024, compared to HKD 287,693,000 as of March 31, 2023, reflecting an increase of approximately 4.9%[15] - The group’s total liabilities included borrowings of HKD 7,300,000 as of June 30, 2024, compared to HKD 4,300,000 as of March 31, 2023, indicating an increase of approximately 69.8%[15] Revenue Segmentation - The electronic manufacturing services segment generated revenue of HKD 247,369,000, while the telecommunications products segment contributed HKD 211,000, resulting in a combined revenue of HKD 458,369,000 from these two segments[12] - Revenue from China reached HKD 33,301 million, while revenue from the United States was HKD 71,726 million, showing significant contributions from both regions[17] - The group’s total revenue from electronic manufacturing services was HKD 16,183 million for the six months ended June 30, 2024, compared to HKD 16,783 million in the previous year, indicating a slight decline[17] - The group’s total revenue from other regions amounted to HKD 49,064 million for the six months ended June 30, 2024, compared to HKD 36,035 million in the previous year, reflecting growth in other markets[17] Operational Costs - The group incurred a total cost of sales of HKD 190,974 million for the six months ended June 30, 2024, compared to HKD 173,777 million in the previous year, reflecting an increase in operational costs[23] - Sales cost rose by 9.9% to HKD 191,000,000, driven by a 15.8% increase in revenue compared to the same period in 2023[49] - Research and development expenses amounted to HKD 5,376 million for the six months ended June 30, 2024, down from HKD 6,636 million in the same period of 2023[24] - The group’s administrative expenses decreased to HKD 48,800,000 from HKD 51,100,000 in 2023, representing 18.4% of total revenue[55] Cash and Liquidity - The company’s cash and cash equivalents were HKD 293,045,000, reflecting a healthy liquidity position[6] - Cash and cash equivalents amounted to HKD 293,000,000, an increase of HKD 21,400,000 from December 31, 2023[60] Future Outlook and Strategy - The company has not provided specific guidance for future performance but continues to focus on operational efficiency and cost management strategies[8] - The company is exploring opportunities for market expansion and potential acquisitions to enhance its growth prospects[8] - The group anticipates continued growth in the renewable energy sector, particularly in energy storage and clean energy, aligning with China's renewable energy development[72] - The company plans to explore potential lending opportunities while maintaining a reasonable risk and return assessment[34] Governance and Compliance - The company has not appointed any individual as "Chief Executive Officer," which deviates from the guidelines of Rule C.2.1[75] - The Audit Committee consists of three members, all of whom are independent non-executive directors, ensuring compliance with governance standards[77] - The company emphasizes the importance of maintaining a balance of power and accountability between the Board and management[75] - The company is committed to reviewing the feasibility of adhering to the guidelines of Rules C.2.1 and C.1.6[76] Credit Risk Management - The company has implemented strict credit policies and control measures to mitigate credit risk, including thorough credit assessments and monitoring of loan quality[38] - The expected credit loss assessment is based on historical credit loss experience and considers specific factors such as the current economic situation and future forecasts[39] - The company conducts internal credit assessments before approving any loan applications, which include verification of identity and background checks[42] - The management is committed to maintaining effective controls and procedures related to loan approvals and collections to minimize potential credit losses[38]

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 （前稱環亞國際醫療科技集團有限公司） （於開曼群島註冊成立的有限公司） （股份代號：1143） (a) 於二零二一年六月三十日配售事項 所得款項淨額 於二零二三年 十二月三十一日 | 公告日期 | （ 概約） | 所得款項淨額擬定用途 | | | | | | | | | | | | | 所得款項淨額實際用途 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 二零二一年 | 22,210,000港元 | 約10,000,000港元用於 (i) | | | | | | | | | 約 | | | ...